Physician profile
Peter Andrawes
NPI 1700141553
$10,643.59
in general payments reported to CMS, 2019-2025
17 companies · $407 in 2025
The $407 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $615 · 2021: $2,111 · 2022: $1,305 · 2023: $2,940 · 2024: $3,265 · 2025: $407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,549 · Food and Beverage: $1,989 · Grant: $987 · Long Term Medical Supply Or Device Loan: $87.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,548.82 |
| Food and Beverage | $1,988.79 |
| Grant | $987.06 |
| Long Term Medical Supply Or Device Loan | $87.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,150.64 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Revolve |
| Allergan, INC. | $2,982.25 | 2020-2022 | |
| Arthrex, INC. | $1,614.22 | 2023 | |
| Acumed LLC | $654.21 | 2022 | |
| Endo Pharmaceuticals INC. | $253.74 | 2022-2023 | Xiaflex |
| Stryker Corporation | $198.99 | 2022 | |
| Integra Lifesciences Corporation | $162.24 | 2024-2025 | Integra, Acell, Integra Dermal Regeneration Template |
| Tactile Systems Technology INC | $111.65 | 2024 | Flexitouch Plus, Entre Plus |
| Axogen | $91.12 | 2024-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
| Mentor Worldwide LLC | $88.23 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Cpx 2 Breast Tissue Expander |
| Davol INC. | $77.85 | 2025 | Arista |
| Acera Surgical, INC. | $76.22 | 2024 | Restrata Wound Matrix |
| Smith+Nephew, INC. | $64.74 | 2023-2025 | Pico 7, Stravix, Grafix Pl |
| Musculoskeletal Transplant Foundation INC. | $51.67 | 2025 | |
| Innovation Technologies INC | $36.93 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $15.30 | 2024 | Va-Lcp |
| Endo USA, INC. | $13.59 | 2024 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Andrawes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.